138 related articles for article (PubMed ID: 11786281)
21. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer.
Yang X; Li G; Ruan C; Hu K; Tang G
Bioconjug Chem; 2023 Nov; 34(11):2133-2143. PubMed ID: 37874952
[TBL] [Abstract][Full Text] [Related]
22. Coligand effects on the solution stability, biodistribution and metabolism of the (99m)Tc-labeled cyclic RGDfK tetramer.
Liu S; Kim YS; Hsieh WY; Gupta Sreerama S
Nucl Med Biol; 2008 Jan; 35(1):111-21. PubMed ID: 18158950
[TBL] [Abstract][Full Text] [Related]
23. Control of radioactivity pharmacokinetics of 99mTc-HYNIC-labeled polypeptides derivatized with ternary ligand complexes.
Ono M; Arano Y; Mukai T; Saga T; Fujioka Y; Ogawa K; Kawashima H; Konishi J; Saji H
Bioconjug Chem; 2002; 13(3):491-501. PubMed ID: 12009938
[TBL] [Abstract][Full Text] [Related]
24. Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.
Kosowicz J; Mikołajczak R; Czepczyński R; Ziemnicka K; Gryczyńska M; Sowiński J
Cancer Biother Radiopharm; 2007 Oct; 22(5):613-28. PubMed ID: 17979564
[TBL] [Abstract][Full Text] [Related]
25. Confirmation of hydrazone formation in HYNIC-peptide conjugate preparation, and its hydrolysis during labeling with (99m)Tc.
Gandomkar M; Najafi R; Shafiei M; Ebrahimi SE
Appl Radiat Isot; 2007 Jul; 65(7):805-8. PubMed ID: 17467277
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
[TBL] [Abstract][Full Text] [Related]
27. Preparation and evaluation of
Maleki F; Masteri Farahani A; Sadeghzadeh N; Mardanshahi A; Abediankenari S
Chem Biol Drug Des; 2020 Nov; 96(5):1223-1231. PubMed ID: 32426902
[TBL] [Abstract][Full Text] [Related]
28. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
29.
Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
J Biomed Sci; 2018 Feb; 25(1):17. PubMed ID: 29455647
[TBL] [Abstract][Full Text] [Related]
30. Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer.
Han Z; Xiao Y; Wang K; Yan J; Xiao Z; Fang F; Jin Z; Liu Y; Sun X; Shen B
J Nucl Med; 2018 Nov; 59(11):1686-1691. PubMed ID: 29777004
[TBL] [Abstract][Full Text] [Related]
31. Investigation of 99mTc-labelling of recombinant human interleukin-2 via hydrazinonicotinamide.
Karczmarczyk U; Garnuszek P; Maurin M; Di Gialleonardo V; Galli F; Signore A; Mikołajczak R
Nucl Med Biol; 2010 Oct; 37(7):795-803. PubMed ID: 20870154
[TBL] [Abstract][Full Text] [Related]
32. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
Dong C; Zhao H; Yang S; Shi J; Huang J; Cui L; Zhong L; Jin X; Li F; Liu Z; Jia B; Wang F
Mol Pharm; 2013 Aug; 10(8):2925-33. PubMed ID: 23768172
[TBL] [Abstract][Full Text] [Related]
33. Preparation and evaluation of
Gan Q; Song X; Zhang X; Zhang J
Eur J Med Chem; 2020 Feb; 188():112032. PubMed ID: 31926467
[TBL] [Abstract][Full Text] [Related]
34. Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41.
Welling MM; Visentin R; Feitsma HI; Lupetti A; Pauwels EK; Nibbering PH
Nucl Med Biol; 2004 May; 31(4):503-9. PubMed ID: 15093821
[TBL] [Abstract][Full Text] [Related]
35. Preparation and biological evaluation of [(99m)Tc/EDDA/Tricine/HYNIC(0), BzThi(3)]-octreotide for somatostatin receptor-positive tumor imaging.
Erfani M; Shafiei M; Mazidi M; Goudarzi M
Cancer Biother Radiopharm; 2013 Apr; 28(3):240-7. PubMed ID: 23464855
[TBL] [Abstract][Full Text] [Related]
36. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.
Ono M; Arano Y; Uehara T; Fujioka Y; Ogawa K; Namba S; Mukai T; Nakayama M; Saji H
Bioconjug Chem; 1999; 10(3):386-94. PubMed ID: 10346868
[TBL] [Abstract][Full Text] [Related]
37. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
Yu F; Lü ML; Zhang XP; Fu D; Hou M; Cai HD; Li D; Wang J; Yuan XY; Lü ZW; Dong F
Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936
[TBL] [Abstract][Full Text] [Related]
38. [
Kolay S; Kumar N; Guleria M; Das T
Bioorg Med Chem Lett; 2024 Jun; 105():129730. PubMed ID: 38583784
[TBL] [Abstract][Full Text] [Related]
39. Study of the
Kaihani S; Sadeghzadeh N
J Labelled Comp Radiopharm; 2020 Dec; 63(14):582-596. PubMed ID: 32997359
[TBL] [Abstract][Full Text] [Related]
40. An improved kit formulation for one-pot synthesis of [
Chakraborty S; Das S; Chakravarty R; Sarma HD; Vatsa R; Shukla J; Mittal BR; Dash A
J Labelled Comp Radiopharm; 2019 Oct; 62(12):823-834. PubMed ID: 31315149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
